Immunohistochemical Expression

Immunohistochemistry (IHC) is an ancillary method, widely used in pathologists’ practice, that allows identifying diagnostic and prognostic/predictive of therapeutic response protein markers on tissue samples by the use of specific monoclonal antibodies and chromogenic substances that guarantee the...

Full description

Saved in:
Bibliographic Details
Format: Online
Language:English
Published: MDPI - Multidisciplinary Digital Publishing Institute 2022
Subjects:
Online Access:ONIX_20220111_9783036504001_168
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1869517133245841408
collection Directory of Open Access Books
description Immunohistochemistry (IHC) is an ancillary method, widely used in pathologists’ practice, that allows identifying diagnostic and prognostic/predictive of therapeutic response protein markers on tissue samples by the use of specific monoclonal antibodies and chromogenic substances that guarantee the visualization of an antibody–antigene binding complex under a light microscope [1]. Coon et al., in 1941 [2], first introduced the use of fluorochrome-conjugated antibodies in clinical practice. Since then, IHC has gone from being a useful tool for identifying the differentiation line of otherwise undifferentiated cells to a technique capable of providing not only diagnostic but also prognostic and predictive indications of responses to specific therapeutic options [1,3]. The abovementioned peculiarities have made IHC one of the most used ancillary methods in the histopathological approach to human neoplastic and non-neoplastic diseases [3-5]. This Special Issue contains 11 accepted papers that provide readers with a comprehensive update on current and future applications of IHC in medical practice.
format Online
id doab-20.500.12854ir-76432
institution Directory of Open Access Books
language eng
publishDate 2022
publishDateRange 2022
publishDateSort 2022
publisher MDPI - Multidisciplinary Digital Publishing Institute
publisherStr MDPI - Multidisciplinary Digital Publishing Institute
record_format ojs
spelling doab-20.500.12854ir-764322024-03-30T23:22:02Z Immunohistochemical Expression Caltabiano, Rosario Loreto, Carla training exercise NGAL VDR kidney heart immunohistochemistry ABCB5 uveal melanoma prognosis metastasis pericardium cytokeratin c-kit PDGFR initial lymphatics macroH2A prognostic factor SLC22A12 URAT1 hypouricemia uric acid transporters excretion fraction of uric acid Hsp27 Hsp60 Hsp70 Hsp90 molecular chaperone chaperonopathies thyroid follicular adenoma follicular carcinoma differential diagnosis carcinogenesis matrix metalloproteinases temporomandibular joint disorder temporomandibular joint DEN liver inflammation ultra-structural changes oxidative stress EGCG Vitamin D prostate cancer urinary tract malformations megacystis enteric nervous system outcome and prognosis WT1 human embryonal/fetal tissues neoplastic tissue n/a thema EDItEUR::M Medicine and Nursing Immunohistochemistry (IHC) is an ancillary method, widely used in pathologists’ practice, that allows identifying diagnostic and prognostic/predictive of therapeutic response protein markers on tissue samples by the use of specific monoclonal antibodies and chromogenic substances that guarantee the visualization of an antibody–antigene binding complex under a light microscope [1]. Coon et al., in 1941 [2], first introduced the use of fluorochrome-conjugated antibodies in clinical practice. Since then, IHC has gone from being a useful tool for identifying the differentiation line of otherwise undifferentiated cells to a technique capable of providing not only diagnostic but also prognostic and predictive indications of responses to specific therapeutic options [1,3]. The abovementioned peculiarities have made IHC one of the most used ancillary methods in the histopathological approach to human neoplastic and non-neoplastic diseases [3-5]. This Special Issue contains 11 accepted papers that provide readers with a comprehensive update on current and future applications of IHC in medical practice. 2022-01-11T13:31:44Z 2022-01-11T13:31:44Z 2021 book ONIX_20220111_9783036504001_168 9783036504001 9783036504018 https://directory.doabooks.org/handle/20.500.12854/76432 eng image/jpeg Attribution 4.0 International https://mdpi.com/books/pdfview/book/3867 https://mdpi.com/books/pdfview/book/3867 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-0401-8 10.3390/books978-3-0365-0401-8 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036504001 9783036504018 168 Basel, Switzerland open access
spellingShingle training exercise
NGAL
VDR
kidney
heart
immunohistochemistry
ABCB5
uveal melanoma
prognosis
metastasis
pericardium
cytokeratin
c-kit
PDGFR
initial lymphatics
macroH2A
prognostic factor
SLC22A12
URAT1
hypouricemia
uric acid transporters
excretion fraction of uric acid
Hsp27
Hsp60
Hsp70
Hsp90
molecular chaperone
chaperonopathies
thyroid
follicular adenoma
follicular carcinoma
differential diagnosis
carcinogenesis
matrix metalloproteinases
temporomandibular joint disorder
temporomandibular joint
DEN
liver
inflammation
ultra-structural changes
oxidative stress
EGCG
Vitamin D
prostate cancer
urinary tract malformations
megacystis
enteric nervous system
outcome and prognosis
WT1
human embryonal/fetal tissues
neoplastic tissue
n/a
thema EDItEUR::M Medicine and Nursing
Immunohistochemical Expression
title Immunohistochemical Expression
title_full Immunohistochemical Expression
title_fullStr Immunohistochemical Expression
title_full_unstemmed Immunohistochemical Expression
title_short Immunohistochemical Expression
title_sort immunohistochemical expression
topic training exercise
NGAL
VDR
kidney
heart
immunohistochemistry
ABCB5
uveal melanoma
prognosis
metastasis
pericardium
cytokeratin
c-kit
PDGFR
initial lymphatics
macroH2A
prognostic factor
SLC22A12
URAT1
hypouricemia
uric acid transporters
excretion fraction of uric acid
Hsp27
Hsp60
Hsp70
Hsp90
molecular chaperone
chaperonopathies
thyroid
follicular adenoma
follicular carcinoma
differential diagnosis
carcinogenesis
matrix metalloproteinases
temporomandibular joint disorder
temporomandibular joint
DEN
liver
inflammation
ultra-structural changes
oxidative stress
EGCG
Vitamin D
prostate cancer
urinary tract malformations
megacystis
enteric nervous system
outcome and prognosis
WT1
human embryonal/fetal tissues
neoplastic tissue
n/a
thema EDItEUR::M Medicine and Nursing
topic_facet training exercise
NGAL
VDR
kidney
heart
immunohistochemistry
ABCB5
uveal melanoma
prognosis
metastasis
pericardium
cytokeratin
c-kit
PDGFR
initial lymphatics
macroH2A
prognostic factor
SLC22A12
URAT1
hypouricemia
uric acid transporters
excretion fraction of uric acid
Hsp27
Hsp60
Hsp70
Hsp90
molecular chaperone
chaperonopathies
thyroid
follicular adenoma
follicular carcinoma
differential diagnosis
carcinogenesis
matrix metalloproteinases
temporomandibular joint disorder
temporomandibular joint
DEN
liver
inflammation
ultra-structural changes
oxidative stress
EGCG
Vitamin D
prostate cancer
urinary tract malformations
megacystis
enteric nervous system
outcome and prognosis
WT1
human embryonal/fetal tissues
neoplastic tissue
n/a
thema EDItEUR::M Medicine and Nursing
url ONIX_20220111_9783036504001_168